A partner across the entire market access journey
Newmarket Strategy is a healthcare and life sciences consultancy helping organisations navigate market access, reimbursement, policy and adoption challenges.
The challenge
Bringing innovation to patients is increasingly complex
Bringing new treatments and technologies to market requires organisations to navigate increasingly complex healthcare systems, policy environments and reimbursement pathways.
Whether launching within a single market or coordinating across multiple regions, success depends on understanding local realities, aligning stakeholder priorities and creating the conditions for sustainable adoption.
Commercial value & access
Demonstrating value, navigating HTA and reimbursement processes, and developing strategies that support successful access across diverse markets.
Health policy & governance
Navigating evolving policy priorities, regulatory change and stakeholder dynamics across national and international healthcare systems.
Adoption & Uptake
Building partnerships with healthcare leaders, payers and decision-makers to drive implementation, scale impact and accelerate adoption.
How we help
Maximising the commercial value and patient impact of great science
We combine deep expertise in market access, policy and healthcare systems to help life sciences organisations navigate complexity, influence decision-makers and accelerate the adoption of innovation. From early strategy through to real-world implementation, our support spans the full journey from opportunity to uptake.
Optimising funding & reimbursement across treatments, therapies & health technologies
From early market access planning and HTA strategy through to reimbursement and commercialisation, we help organisations demonstrate value, navigate complexity and create clear pathways to adoption.
Influence the decisions that shape commercial success
We help life sciences organisations navigate complex policy environments, engage key stakeholders and shape decisions that improve market access, patient access and commercial outcomes. Through dedicated global policy and government affairs, we provide specialist support across national and international healthcare systems.
Drive access & adoption through evidence generation
We support organisations to generate evidence needed to demonstrate value, navigate reimbursement processes and support successful market access to help clients make stronger decisions and achieve better outcomes.
Why us
Unrivalled experience in the health systems and reimbursement policies we advise on
As a specialist life sciences consultancy, we combine expertise across healthcare policy, market access, reimbursement and adoption.
Deep expertise
Former pharmaceutical, government, health system and HTA body leaders.
End-to-end support
Policy, access and evidence, all best in class.
Global perspective
Supporting UK and international objectives.
Practical advice
Strategic thinking based on in-market delivery.
Our team
Practical advice from people who understand the market
Newmarket Strategy brings together market access specialists, healthcare policy experts, clinicians, analysts and commercial strategists.
Proven approaches to driving policy, access and reimbursement
Clients supported globally
People across specialist practice areas
Years supporting healthcare and life sciences clients
case studies
Proven impact across the healthcare innovation journey
From market access and government affairs to health system adoption, we help organisations navigate complex challenges, influence decision-makers and accelerate access to innovation. Explore a selection of anonymised examples showcasing our approach and impact.
Our insights
Dive into our latest insights & thinking
Practical thinking on the access, policy, commercial and health system issues shaping healthcare and life sciences.
FAQ
Your questions answered
Newmarket Strategy helps healthcare, life sciences and health tech organisations make better decisions across policy, market access, reimbursement, evidence and commercial strategy.
We bring together senior experience from industry, government, the NHS, reimbursement bodies and clinical practice. Our teams combine expertise in global health policy, health economics and evidence synthesis, and value and access, giving clients connected advice grounded in how healthcare decisions are made.
Yes. We help healthcare and life sciences organisations demonstrate the value of their innovations and navigate routes to access and reimbursement. By bringing together commercial strategy, policy insight and robust evidence, we help clients plan how to bring their products to market and support their adoption.